CRISPR Therapeutics AG (NASDAQ:CRSP)
| 88.73 BATS BZX Real-Time Price As of 12:50pm ET |  -3.38 / -3.67%Today’s Change | 32.30 Today|||52-Week Range 111.90 | +45.69% Year-to-Date |
Stock Price Forecast
The 15 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 105.00, with a high estimate of 140.00 and a low estimate of 47.00. The median estimate represents a +18.34% increase from the last price of 88.73.
Analyst Recommendations
The current consensus among 18 polled investment analysts is to Buy stock in CRISPR Therapeutics AG. This rating has held steady since October, when it was unchanged from a rating.Move your mouse over past
months for detail
Earnings and Sales Forecasts
Current Quarter
Earnings per Share
-$1.17
-$1.17
Sales
$2.1M
$2.1M
Reporting Date
Nov 04
Nov 04
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.
Growthquarterly 9.68%
Growthannually -507.04%
Sales
Growthquarterly 4,583.44%
Growthannually -97.86%
